National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample
Mr. Frankel et al., National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample, HEAL SERV R, 34(5), 1999, pp. 969-992
Citations number
7
Categorie Soggetti
Public Health & Health Care Science","Health Care Sciences & Services
Objective. The design and implementation of a nationally representative pro
bability sample of persons with a low-prevalence disease, HIV/AIDS.
Data Sources/Study Setting. One of the most significant roadblocks to the g
eneralizability of primary data collected about persons with a low-prevalen
ce disease is the lack of a complete methodology for efficiently generating
and enrolling probability samples. The methodology developed by the HCSUS
consortium uses a flexible, provider-based approach to multistage sampling
that minimizes the quantity of data necessary for implementation.
Study Design. To produce a valid national probability sample, we combined a
provider-based multistage design with the M.D.-colleague recruitment model
often used in non-probability site-specific studies.
Data Collection. Across the contiguous United States, reported AIDS cases f
or metropolitan areas and rural counties. In selected areas, caseloads for
known providers for HIV patients and a random sample of other providers. Fo
r selected providers, anonymous patient visit records.
Principal Findings. It was possible to obtain all data necessary to impleme
nt a multistage design for sampling individual HIV-infected persons under m
edical care with known probabilities. Taking account of both patient and pr
ovider nonresponse, we succeeded in obtaining in-person or proxy interviews
from subjects representing over 70 percent of the eligible target populati
on.
Conclusions. It is possible to design and implement a national probability
sample of persons with a low-prevalence disease, even if it is stigmatized.